Parkinson's Disease Trial, Recruiting (NCT05656586)

Parkinson's Disease Trial, Recruiting NCT05656586 Sponsor: University of Minnesota Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05656586 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are currently receiving Deep Brain Stimulation (DBS) therapy targeting a specific area of the brain (called the globus pallidus) to treat Parkinson's disease
Your DBS device is a Medtronic Percept system (a specific brand/type of implanted brain stimulator)
It has been at least 3 months since your DBS device was first switched on
For one part of the study called the "At Home" experiment only: your DBS device settings must be compatible with a brain signal recording (sensing) feature (confirm with trial site)

Who may not be able to join:

You have a history of bone, joint, or muscle problems that would significantly affect your ability to perform the physical movement tasks required in the study
You have a history of dementia or significant memory/thinking difficulties
You have another significant neurological (brain or nerve) condition, as decided by the lead researcher
You have had complications or side effects from your DBS surgery or stimulation (for example, unwanted muscle movements when the device is on) that could affect your safety or the study results
You are not able to give informed consent to take part in the study, as assessed using a specific assessment tool called the MacCAT-CR

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 612-625-8938

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05656586

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 612-625-8938

More information: https://clinicaltrials.gov/study/NCT05656586

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are currently receiving Deep Brain Stimulation (DBS) therapy targeting a specific area of the brain (called the globus pallidus) to treat Parkinson's disease
Your DBS device is a Medtronic Percept system (a specific brand/type of implanted brain stimulator)
It has been at least 3 months since your DBS device was first switched on
For one part of the study called the "At Home" experiment only: your DBS device settings must be compatible with a brain signal recording (sensing) feature (confirm with trial site)

Who may not be able to join:

You have a history of bone, joint, or muscle problems that would significantly affect your ability to perform the physical movement tasks required in the study
You have a history of dementia or significant memory/thinking difficulties
You have another significant neurological (brain or nerve) condition, as decided by the lead researcher
You have had complications or side effects from your DBS surgery or stimulation (for example, unwanted muscle movements when the device is on) that could affect your safety or the study results
You are not able to give informed consent to take part in the study, as assessed using a specific assessment tool called the MacCAT-CR

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

1 January 2023

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peak negative power; Stride length; Alpha power during standardized daily gait assessment; cadence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov